(219) 878-5031 | Schedule Appointment |

 PRIVACY PRACTICES & PATIENT DISCLOSURES Practice: Glazer Facial Plastic & Cosmetic Surgery

Effective Date: February 03, 2026

This practice is a HIPAA-covered entity, and most patient information qualifies as protected health information (PHI) exempt from the Indiana Consumer Data Protection Act (INCDPA). The following summarizes INCDPA rights where they may apply to non-PHI personal data (e.g., certain website/marketing interactions). We primarily handle patient data under HIPAA privacy rules. Our full Notice of Privacy Practices is available upon request or at [link/location].

  1. INDIANA CONSUMER DATA PRIVACY (INCDPA) As of January 1, 2026, Indiana residents have expanded rights regarding their personal data. We comply with the Indiana Consumer Data Protection Act:

  • Right to Access & Confirm: You have the right to confirm if we are processing your personal data and to access that data.

  • Right to Delete & Correct: You may request that we delete personal data you provided or correct inaccuracies in your file.

  • Right to Data Portability: You may request a copy of your data in a portable, readily usable format.

  • Right to Opt-Out: You have the right to opt-out of the processing of your data for targeted advertising or profiling. We do not sell your personal data.

  1. MANDATORY 42 CFR PART 2 ALIGNMENT (FEDERAL) In accordance with the February 16, 2026, federal alignment of HIPAA and 42 CFR Part 2:

  • Strict Confidentiality: If any records relate to substance use disorder (SUD) treatment from "Part 2" programs, these records carry heightened protections. These records—or testimony regarding them—shall not be used or disclosed in any civil, criminal, or administrative proceedings against you without your specific written consent or a court order.

  • Notice of Redisclosure: Once information is disclosed pursuant to your authorization (especially via unencrypted email/SMS), it may no longer be protected by federal or state privacy rules.

  1. SENSITIVE DATA & BIOMETRICS (INCDPA COMPLIANCE) Indiana law requires explicit opt-in consent for "Sensitive Data."

  • Biometric Data: We collect high-resolution facial scans and 3D imagery ("Biometric Data") solely for clinical purposes (e.g., treatment planning, mapping, and progress tracking). This biometric data is processed only as necessary for your care and is protected under HIPAA. We do not use it for identification outside treatment or share it for non-healthcare purposes without authorization. By signing our consent, you provide the "clear affirmative act" required by Indiana law for us to process this sensitive information.

  • Health Diagnosis: We treat all information regarding your physical health or medical diagnoses as sensitive data with restricted access.

  1. INDIANA SB 282 & PHARMACY BOARD STANDARDS (NEW 2026) In response to Indiana Senate Bill 282, we maintain rigorous oversight of all "Prescription-Only" medical treatments:

  • Serious Adverse Event Reporting: We are required to report any "serious adverse events" (resulting in hospitalization or significant incapacity) to the relevant boards within 5 days.

  • Compounding Transparency: If you receive compounded medications (e.g., specific IV drips or GLP-1/Weight Loss peptides), we maintain detailed "lot-tracking" and source documentation from FDA-inspected manufacturers, available for state audit.

  1. GOOD FAITH EXAMS (GFE) & INDIANA SUPERVISION

  • Corporate Practice of Medicine (CPOM): [Clinic Name] operates in compliance with Indiana’s CPOM standards. All medical procedures are performed under a delegated practice agreement with our Medical Director.

  • Mandatory Evaluation: Before your first treatment with Botox, Fillers, or Lasers, you must receive a Good Faith Exam (GFE) from a physician, NP, or PA. RNs and Estheticians may not establish the "Patient-Provider Relationship" or prescribe your treatment plan.

  1. DIGITAL MARKETING & RESPONSE TIMES

  • 45-Day Response: Per Indiana law, we will respond to any data rights request within 45 days.

  • Targeted Advertising: We do not use "Sensitive Data" (like your specific diagnosis) for targeted social media ads. Our website honors browser-based "Do Not Track" signals.

  1. CONTACT OUR PRIVACY OFFICER To exercise your Indiana Data Rights, for 42 CFR Part 2 concerns, or to request our full HIPAA Notice of Privacy Practices:

  1. ACKNOWLEDGMENT OF GENERAL RISKS Patients must acknowledge these risks via a separate consent form before treatment. By using our services and accessing this site, you acknowledge that all medical-grade aesthetic treatments carry inherent risks, including but not limited to:

  • Neuromodulators (Botox/Dysport): Risk of localized bruising, headache, eyelid ptosis (drooping), and the rare but serious risk of toxin spread causing difficulty breathing or swallowing.

  • Dermal Fillers: Risk of swelling, lumps, and the rare but critical risk of Vascular Occlusion (blood vessel blockage), which can lead to skin necrosis or permanent vision loss.

  • Biostimulators (Sculptra/Radiesse): Risk of delayed-onset nodules (bumps) that may appear months post-treatment and injection site tenderness.

  • Emergency Protocol: In the event of a "Serious Adverse Event" (as defined by SB 282), Glazer Facial Plastic & Cosmetic Surgery is mandated to report the occurrence to the Indiana Board of Pharmacy within 5 days.

Cart (0)